Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

Treatments and trials you qualify for
Education for your stage of care
Financial support for your medications
Solutions to your side effects

Learn more about HealthTree

Video

Why don't all cases of MDS turn into AML?

Description

Learn about the reason that all cases of MDS don't turn into AML in this HealthTree University lesson by a cancer specialist.

On this video

Srinivasa Sanikommu, MD, Specialist

Levine Cancer Institute

Transcript

Why don't all cases of MDS turn into AML? It depends on what's going on in the bone marrow and the stem cells. So if they have high risk cytogenetics that I described, most of the times they do progress. It's only a matter of time. As I said, MDS is in the older patients and they may have other competing medical problems going on. So high risk MDS most of the times progresses. We don't know when, but most of the times they do. Low risk is, we're still learning more about what causes the progression versus not. Some patients, even if it is low risk, can progress faster versus... That's why we need more research into this area.

Related Content